Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P990064/S094

Mosaic Neo Mitral Bioprosthesis

Medtronic, Inc. · Decision date Mar 3, 2026

FDA DECISIONP990064/S094

What did the FDA approve?

FDA records P990064/S094 as a supplement to PMA P990064, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Mar 3, 2026.

FDA approval order statement

approval for updates to the sewing cuff, suture markings, radiopaque marker, holder, and sizers.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Mar 3, 2026
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P990064/S094
Regulatory pathway
PMA supplement
Product code
DYE
Decision code
APPR
Decision date
Mar 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: replacement Heart-valve.

Product code
DYE
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P990064/S094 received

    Application receipt date recorded by FDA.

  2. P990064/S095 · Related supplement

    Mosaic Bioprosthesis, Models 305, 310

  3. P990064/S094 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P990064. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P990064

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementOct 23, 2025FDA
Medtronic, Inc.PMA supplementNov 10, 2025FDA
Medtronic, Inc.PMA supplementFeb 12, 2026FDA

Explore the linked device profile

Other records with product code DYE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
1851 E. Deere Ave., Santa Ana, CA, 92705

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records